Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Elm And Carlton St
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-845-1110- Is this information wrong?
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2006 - 2009
University at BuffaloResidency, Internal Medicine, 2003 - 2006
Shanghai Medical UniversityClass of 1992
Certifications & Licensure
NY State Medical License 2009 - 2025
MD State Medical License 2006 - 2010- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) Start of enrollment: 2015 Jun 26
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsFluctuations in Gut Microbiome Composition During Immune Checkpoint Inhibitor Therapy.Joy Sarkar, Eduardo Cortes Gomez, Takaaki Oba, Hongbin Chen, Grace K Dy, Brahm H Segal, Marc S Ernstoff, Fumito Ito> ;World Journal of Oncology. 2023 Jun 1
- 1 citationsPredictive and Prognostic Implications of Circulating CX3CR1CD8T Cells in Non-Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy.Eihab Abdelfatah, Mark D Long, Ryutaro Kajihara, Takaaki Oba, Takayoshi Yamauchi, Hongbin Chen, Joy Sarkar, Kristopher Attwood, Junko Matsuzaki, Brahm H Segal, Grace K...> ;Cancer Research Communications. 2023 Mar 1
- 1 citationsSurvival outcomes of alternate dosing schedule of pemetrexed as maintenance therapy in NSCLC: Single institution experience.Mark G Faber, Chong Wang, Sruthi Kommi Reddy, Alison Meagher, Amy Early, Hongbin Chen, Grace K Dy> ;Lung Cancer. 2022 Mar 1
- Join now to see all
Press Mentions
- Roswell Park Researchers Identify New Biomarker of Response to Checkpoint InhibitorsMarch 3rd, 2021
- Predisposing Factors and Radiological Features in Patients with Internal Carotid Artery Dissection or Vertebral Artery DissectionDecember 10th, 2020
Professional Memberships
- Member
- Member
Hospital Affiliations
Roswell Park Comprehensive Cancer CenterBuffalo, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
